What is NDC 68180-989?

68180-989 is the product NDC for Droxidopa, Droxidopa 300 mg/1 capsule, listed with the FDA by Lupin Pharmaceuticals, Inc..

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Droxidopa?

41 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Droxidopa NDC 68180-989 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-989Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0989Add the package segment from the table below.

Product information

Brand name (proprietary): Droxidopa
Generic name (nonproprietary): droxidopa
Active ingredients: Droxidopa — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211652
Marketing start: Sep 24, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Catecholamines (Chemical structure)Increased Blood Pressure (Physiologic effect)
Identifiers: Product ID 68180-989_0098094d-a0c0-4b55-9851-68aaf0109233SPL ID 0098094d-a0c0-4b55-9851-68aaf0109233SPL set ID 81b798dc-b8dc-48a5-af46-82bb55f789a8RxCUI 1490026, 1490034, 1490038UNII J7A92W69L7UPC 0368180989097

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Dec 18, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Droxidopa capsules are indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks of treatment has not been established. The continued effectiveness of droxidopa capsules should be assessed periodically. Droxidopa capsules are indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to blac…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-989

What is NDC 68180-989?: 68180-989 is the product NDC for Droxidopa, Droxidopa 300 mg/1 capsule, listed with the FDA by Lupin Pharmaceuticals, Inc..
What drug is associated with this NDC?: Droxidopa.
What is the active ingredient?: Droxidopa.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Droxidopa?: 41 other product NDCs are listed under this name. See all Droxidopa NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Droxidopa NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Droxidopa	Droxidopa 100 mg/1	CapsuleOral	CivicaScript LLC	82249-551	82249-0551-90
Droxidopa	Droxidopa 200 mg/1	CapsuleOral	CivicaScript LLC	82249-552	82249-0552-90
Droxidopa	Droxidopa 300 mg/1	CapsuleOral	CivicaScript LLC	82249-554	82249-0554-90
droxidopa	Droxidopa 100 mg/1	CapsuleOral	Slate Run Pharmaceuticals, LLC	70436-140	70436-0140-06
droxidopa	Droxidopa 200 mg/1	CapsuleOral	Slate Run Pharmaceuticals, LLC	70436-141	70436-0141-06
droxidopa	Droxidopa 300 mg/1	CapsuleOral	Slate Run Pharmaceuticals, LLC	70436-142	70436-0142-06
Droxidopa	Droxidopa 100 mg/1	CapsuleOral	Bionpharma Inc.	69452-256	69452-0256-19
Droxidopa	Droxidopa 200 mg/1	CapsuleOral	Bionpharma Inc.	69452-257	69452-0257-19
Droxidopa	Droxidopa 300 mg/1	CapsuleOral	Bionpharma Inc.	69452-258	69452-0258-19
Droxidopa	Droxidopa 100 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-987	—

All 42 Droxidopa NDCs

Other NDCs under ANDA 211652

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211652
Product	Strength	Form · route	Labeler	Product NDC
Droxidopa	Droxidopa 100 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-987
Droxidopa	Droxidopa 200 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-988